Development of a folate-conjugated, pH-responsive magnetic nanocarrier based on graphene oxide-g-poly(N-vinylformamide/allylamine) for doxorubicin drug delivery
In this study, a folic acid-conjugated pH-responsive copolymer grafted onto magnetic carboxylated graphene oxide (MCGO) was developed and evaluated for doxorubicin (DOX) adsorption and release. Functionalization of MCGO with allyl alcohol (AOH) introduced vinyl groups that served as initiation sites for free-radical polymerization and grafting of the N -vinylformamide (VF)/allylamine (AN) chains. Subsequent conjugation of folic acid (FA) was designed to enhance the potential for folate receptor-associated cellular interaction. Structural and physicochemical characterization using FTIR, XRD, BET, TGA, VSM, FE-SEM/EDX, TEM, and zeta potential/DLS analyses confirmed the successful fabrication of the nanocomposite. The surface area and pore volume of MCGO-p(VF/AN)-FA were 82.68 m 2 g −1 and 0.21 cm 3 g −1 , respectively, roughly ten times higher than those of CGO. The synthesized composite exhibited high DOX adsorption capacity under selected conditions (pH: 8, temperature: 55 °C, contact time: 45 min), evaluated via a one-factor-at-a-time approach. Adsorption kinetics followed a pseudo-second-order model, while the Langmuir isotherm provided the best fit, with a maximum adsorption capacity of 126.619 mg g −1 at 55 °C. Drug release studies revealed enhanced release under mildly acidic conditions, with 88% of the DOX released at pH 5.6 over 48 h at 37 °C. in-vitro studies implied a formulation-dependent biological response, with the FA-conjugated nanocarrier showing a numerical trend toward greater cytotoxicity against MDA-MB-231 breast cancer cells compared with the non-folate system, alongside acceptable biocompatibility toward MCF-10A normal cells (>70% viability). In addition, the competitive inhibition assay utilizing free folic acid resulted in a restoration of MDA-MB-231 cell viability to 98.76%, providing supportive evidence for the involvement of FR-mediated cellular interactions. However, direct quantitative uptake and intracellular trafficking remain to be verified by flow cytometry and confocal imaging in future studies.
Authors
- Mahsasadat Miralinaghi (ORCID: https://orcid.org/0000-0002-7629-6464)
- Amir Heydarinasab (ORCID: https://orcid.org/0000-0002-0417-4863)
- Elham Moniri (ORCID: https://orcid.org/0000-0002-1961-9298)
- Babak Feizi (ORCID: https://orcid.org/0009-0001-5292-7380)
- Afshar Eskandarisefat (ORCID: https://orcid.org/0009-0005-6325-2728)
Institutions
- Islamic Azad University, Tehran (IR)
- Islamic Azad University of Varamin (IR)
Publication Details
- Journal
- Journal of Saudi Chemical Society
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s44442-026-00139-w
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00